Why study erythropoietin in preterm infants?

Acta Paediatrica, International Journal of Paediatrics

Volumn 102, Issue 6, 2013, Pages 567-568

  Ohls, Robin K ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; IRON; RECOMBINANT ERYTHROPOIETIN;

BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CONTINUOUS INFUSION; ERYTHROPOIESIS; HOSPITALIZATION; HUMAN; IN VITRO STUDY; INTENSIVE CARE UNIT; NEUROPROTECTION; NOTE; PHLEBOTOMY; PREMATURITY; PRIORITY JOURNAL;

ANEMIA; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; RECOMBINANT PROTEINS;

EID: 84877584093     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12234     Document Type: Note

References (12)

1. Zipursky A,. Erythropoietin therapy for premature infants: cost without benefit? Pediatr Res 2000; 48: 136.
2. Ohls RK, Christensen RD, Kamath-Rayne BD, Rosenberg A, Wiedmeier SE, Roohi M, et al. A randomized, masked, placebo controlled study of darbepoetin administered to preterm infants. Pediatrics 2013; in press.
3. Ohlsson A, Aher SM,. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; 3: CD004863.
4. Aher S, Ohlsson A,. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; 3: CD004868.
5. Christensen RD,. Association between red blood cell transfusions and necrotizing enterocolitis. J Pediatr 2011; 158: 349-50.
6. Baer VL, Lambert DK, Henry E, Snow GL, Christensen RD,. Red blood cell transfusion of preterm neonates with a Grade 1 intraventricular hemorrhage is associated with extension to a Grade 3 or 4 hemorrhage. Transfusion 2011; 51: 1933-9.
7. Costa S, Romagnoli C, Zuppa AA, Cota F, Scorrano A, Gallini F, et al. How to administer erythropoietin, intravenous or subcutaneous? Acta Paediatr 2013; 102: [Epub].
8. Ohls RK, Veerman MW, Christensen RD,. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in parenteral nutrition solution. J Pediatr 1996; 128: 518-23.
9. Ohls RK, Roohi M, Peceny HM, Schrader R, Bierer R,. A randomized, masked study of weekly erythropoietin dosing in preterm infants. J Pediatr 2012; 160: 790-5.
10. Romagnoli C, Zecca E, Gallini F, Girlando P, Zuppa AA,. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr 2000; 159: 627-8.
11. McAdams RM, McPherson RJ, Mayock DE, Juul SE,. Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol 2013; 33: 226-30.
12. Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, Mayock DE, et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics 2012; 130: 683-91.